Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1994 1
2000 1
2003 1
2006 2
2007 2
2008 2
2009 1
2010 1
2011 7
2012 5
2013 5
2014 14
2015 10
2016 6
2017 13
2018 4
2019 5
2020 8
2021 11
2022 5
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Oxybutynin as an alternative treatment for hyperhidrosis.
Delort S, Marchi E, Corrêa MA. Delort S, et al. An Bras Dermatol. 2017 Mar-Apr;92(2):217-220. doi: 10.1590/abd1806-4841.201755126. An Bras Dermatol. 2017. PMID: 28538882 Free PMC article. Review.
Hyperhidrosis is the excessive production of sweating, which can be primary and focal or secondary to various pathologies. ...Many treatment options are proposed, both clinical and surgical. The aim of this review is to focus on the treatment of hyperhidrosis with
Hyperhidrosis is the excessive production of sweating, which can be primary and focal or secondary to various pathologies. ...Many tr
Safety and efficacy of oxybutynin in patients with hyperhidrosis: systematic review and meta-analysis of randomized controlled trials.
El-Samahy M, Mouffokes A, Badawy MM, Amro S, Fayad T, Abdelwahab OA. El-Samahy M, et al. Arch Dermatol Res. 2023 Oct;315(8):2215-2226. doi: 10.1007/s00403-023-02587-5. Epub 2023 Mar 4. Arch Dermatol Res. 2023. PMID: 36869926 Free PMC article. Review.
We aim to investigate patient satisfaction and the effectiveness of oxybutynin in treating hyperhidrosis. METHODS: We prospectively registered the protocol of this systematic review and meta-analysis on PROSPERO (CRD 42022342667). ...CONCLUSION: Our study suggests t …
We aim to investigate patient satisfaction and the effectiveness of oxybutynin in treating hyperhidrosis. METHODS: We prospect …
Oxybutynin in primary hyperhidrosis: A long-term real-life study.
Almeida ART, Ferrari F, Restrepo MVS, Rocha VB. Almeida ART, et al. Dermatol Ther. 2020 Nov;33(6):e14344. doi: 10.1111/dth.14344. Epub 2020 Oct 5. Dermatol Ther. 2020. PMID: 32981151
This study aims to evaluate the oral oxybutynin effectiveness in hyperhidrosis, besides its tolerance and safety. In a real-life long-term study, 30 patients with primary hyperhidrosis and Hyperhidrosis Disease Severity Scale (HDSS) with score of at le …
This study aims to evaluate the oral oxybutynin effectiveness in hyperhidrosis, besides its tolerance and safety. In a real-li …
Management of Primary Focal Hyperhidrosis: An Algorithmic Approach.
Liu V, Farshchian M, Potts GA. Liu V, et al. J Drugs Dermatol. 2021 May 1;20(5):523-528. doi: 10.36849/JDD.5774. J Drugs Dermatol. 2021. PMID: 33938689 Review.
Hyperhidrosis (HH) is defined as perspiration beyond the level required to maintain temperature regulation. ...Despite minimizing sweating, chronic use of systemic anticholinergics, in particular oxybutynin, may result in detrimental adverse effects such as dementia
Hyperhidrosis (HH) is defined as perspiration beyond the level required to maintain temperature regulation. ...Despite minimizing swe
The treatment of palmar hyperhidrosis - a systematic review.
Chudry H. Chudry H. Int J Dermatol. 2022 Nov;61(11):1303-1310. doi: 10.1111/ijd.15937. Epub 2021 Oct 15. Int J Dermatol. 2022. PMID: 34653261 Review.
BACKGROUND: Primary palmar hyperhidrosis (PH) can have a significantly negative impact on an individual's quality of life. ...RESULTS: Of the 574 references yielded, six met the inclusion criteria and were analyzed for this review. Two studies evaluated the use of oral …
BACKGROUND: Primary palmar hyperhidrosis (PH) can have a significantly negative impact on an individual's quality of life. ...RESULTS …
Oxybutynin for the Treatment of Primary Hyperhidrosis: Current State of the Art.
Campanati A, Gregoriou S, Kontochristopoulos G, Offidani A. Campanati A, et al. Skin Appendage Disord. 2015 Mar;1(1):6-13. doi: 10.1159/000371581. Epub 2015 Jan 30. Skin Appendage Disord. 2015. PMID: 27172124 Free PMC article. Review.
Oxybutynin is an anticholinergic drug with an emerging role in the treatment of hyperhidrosis. Several recent studies have documented that it is effective both in focal and generalized hyperhidrosis and shows universally good response among different groups o
Oxybutynin is an anticholinergic drug with an emerging role in the treatment of hyperhidrosis. Several recent studies have doc
Oxybutynin for hyperhidrosis.
Lefrandt JD, Maurer JM. Lefrandt JD, et al. Neth J Med. 2007 Oct;65(9):356. Neth J Med. 2007. PMID: 17954957 Free article. No abstract available.
Oxybutynin for Primary Palmer Hyperhidrosis Attenuates Migraine Attacks and Burdens.
Katsuki M. Katsuki M. Cureus. 2023 Sep 7;15(9):e44826. doi: 10.7759/cureus.44826. eCollection 2023 Sep. Cureus. 2023. PMID: 37818504 Free PMC article.
Primary hyperhidrosis can cause anxiety, and stress, including anxiety, is the most common inducer of migraine headaches. Recently, oxybutynin has been used for primary palmar hyperhidrosis. We herein describe a 26-year-old female migraine patient with primar …
Primary hyperhidrosis can cause anxiety, and stress, including anxiety, is the most common inducer of migraine headaches. Recently, …
Oxybutynin: dry days for patients with hyperhidrosis.
Mijnhout GS, Kloosterman H, Simsek S, Strack van Schijndel RJ, Netelenbos JC. Mijnhout GS, et al. Neth J Med. 2006 Oct;64(9):326-8. Neth J Med. 2006. PMID: 17057269 Free article. Review.
Oxybutynin is not approved for hyperhidrosis, explaining the unfamiliarity with this medicine. ...Therefore, oxybutynin merits consideration in patients with idiopathic hyperhidrosis. ...
Oxybutynin is not approved for hyperhidrosis, explaining the unfamiliarity with this medicine. ...Therefore, oxybutynin
106 results